Global Cord Blood Corporation (CORBF)
OTCMKTS · Delayed Price · Currency is USD
0.8001
-0.1499 (-15.78%)
At close: Dec 16, 2025
Global Cord Blood Market Cap
Global Cord Blood has a market cap or net worth of $107.15 million as of December 17, 2025. Its market cap has decreased by -40.73% in one year.
Market Cap
107.15M
Enterprise Value
n/a
Revenue
196.10M
Ranking
n/a
PE Ratio
1.23
Stock Price
$0.80
Market Cap Chart
Since July 1, 2009, Global Cord Blood's market cap has decreased from 968.15M to 107.15M, a decrease of -88.93%. That is a compound annual growth rate of -12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 127.22M | -36.67% |
| Dec 31, 2024 | 200.87M | 22.95% |
| Dec 29, 2023 | 163.38M | -67.92% |
| Dec 31, 2021 | 509.30M | 12.94% |
| Dec 31, 2020 | 450.95M | -25.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 398.68M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |